Find Grants for Non-profits
Find out if you qualify for verified grants for Non-profits. Discover your eligibility and key funding details for Non-profits from major foundations and government agencies.
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-268
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-267
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-287
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-286
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-235
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242, 93.879
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Deadline: May 7, 2027
Opportunity Number: PAR-26-001
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAR-25-254
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.399
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Deadline: October 8, 2027
Opportunity Number: PAR-25-248
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: October 8, 2027
Status: Posted
CFDA Numbers: 93.393
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Deadline: November 18, 2027
Opportunity Number: RFA-DA-26-034
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 18, 2027
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Deadline: October 14, 2027
Opportunity Number: PAR-25-135
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: October 14, 2027
Status: Posted
CFDA Numbers: 93.398
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Deadline: November 19, 2026
Opportunity Number: PAR-25-052
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.853
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-112
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-113
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-243
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-244
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.393
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-038
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-037
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
Deadline: February 15, 2026
Opportunity Number: RFA-HG-25-005
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: February 15, 2026
Status: Posted
CFDA Numbers: 93.172
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-228
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.879, 93.172
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-229
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.172, 93.879
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-176
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.351
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-069
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-070
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-124
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-126
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
